Innovation Pharmaceuticals Inc (IPIX)

[DaubersUP]

Agree. Validive was just licensed for 1 million upfront - 108 million in milestones to approval...not sure if phase 3 costs were included but also double digit royalties that can rise as sales increase.

That was for an OM drug that had weak data.


If b-OM sticks 80% prevention. Game-over. We will take the entire market share imo.

HPV induced H&N cancers are on the rise 6 fold. And expected to rise over the next 10-15 years.

Big big money in this market